Advanced Concepts in Human Immunology: Prospects for Disease Control

1. Human Chronic Viruses: Pathogenesis, host response, and treatmentMatilda Hoffman, DeGaulle I. Chigbu, Brenndan L. Crumley, Ravi Sharma, Sergey Pustylnikov, Thomas Crilley, Rashida Ginwala, Zafar K. Khan, Pooja Jain

2. Defining the Role of Immunoproteomics in Human ImmunotherapyJoseph Comber, Ramila Philip

3. Microbiome and Cellular Players in Type 1 Diabetes: From Pathogenesis to ProtectionDarshan Badal, Mahinder Paul, Neenu Jacob, Naresh Sachdeva

4. Immune Mechanisms, Pathology, and Management of Allergic Ocular DiseasesDeGaulle I. Chigbu, Pooja Jain, Zafar K. Khan

5. Dendritic Cell-regulated T Cell Immunity and Tolerance against Acute Myeloid LeukemiaYuanyuan Tian, Hongshuang Yu, Shaoyan Hu, Yi Zhang

6. Perspectives on the Role of T cell Negative Immune Checkpoint Receptors in Health and DiseaseTsuyoshi Fujita, Danielle Clements, Thomas A. Premeaux, Lishomwa C. Ndhlovu

7. Neuroprotective Immunity for Neurodegenerative and Neuroinfectious DiseasesKatherine E. Olson, R. Lee Mosley, Howard E. Gendelman

8. Polycystic Ovary Syndrome: An Overview of a complex, heterogeneous, genetic condition including pathophysiologyShailaja Nair, Yolaine Nkamga, Bryson Hoover-Hankerson

Pooja Jain, PhD, is a Professor in the Department of Microbiology and Immunology as well as Neurobiology and Anatomy at the Drexel University College of Medicine located in Philadelphia, USA. Her research focuses on the host-pathogen interactions underlying Adult T-Cell Leukemia Lymphoma (ATLL) induced by Human T-cell leukemia virus type 1 (HTLV-1). In addition, her Dr. Jain's laboratory is engaged in testing novel targets for myeloid cell-immunotherapy against neuroinflammtory diseases such as Multiple Sclerosis and HAM/TSP (HTLV-associated myelopathy/tropical spastic paraparesis).Lishomwa C. Ndhlovu, PhD, is a Professor at the John A. Burns School of Medicine, University of Hawaii. His research focuses on understanding the impact of HIV on the immune system as well as how this host-HIV interaction will inform potential clinical applications in balancing strategies to slow or eliminate HIV infection and optimize quality of life outcomes. Dr. Ndhlovu's laboratory is also investigating the role of negative checkpoint regulators (NCR) in HIV, as potential immunotherapy that reverse immune perturbation in HIV.